153 related articles for article (PubMed ID: 36240057)
1. Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus.
Dubinski I; Bechtold-Dalla Pozza S; Schmidt H
J Pediatr Endocrinol Metab; 2022 Dec; 35(12):1544-1546. PubMed ID: 36240057
[TBL] [Abstract][Full Text] [Related]
2. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
4. Gefitinib Treatment Was Unsuccessful for Central Diabetes Insipidus Due to Pituitary Metastasis of Lung Adenocarcinoma.
Tanaka S; Hirabayashi T; Kimoto M; Hama M; Hachiya T; Gomi K
Intern Med; 2021 Apr; 60(7):1073-1076. PubMed ID: 33162476
[TBL] [Abstract][Full Text] [Related]
5. Management of central diabetes insipidus.
Garrahy A; Thompson CJ
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
[TBL] [Abstract][Full Text] [Related]
6. Central diabetes insipidus secondary to COVID-19 infection: a case report.
Yavari A; Sharifan Z; Larijani B; Mosadegh Khah A
BMC Endocr Disord; 2022 May; 22(1):134. PubMed ID: 35590312
[TBL] [Abstract][Full Text] [Related]
7. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
8. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
Cunnah D; Ross G; Besser GM
Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
[TBL] [Abstract][Full Text] [Related]
9. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
10. Diabetes insipidus and pregnancy.
Chanson P; Salenave S
Ann Endocrinol (Paris); 2016 Jun; 77(2):135-8. PubMed ID: 27172867
[TBL] [Abstract][Full Text] [Related]
11. Oral desmopressin treatment of central diabetes insipidus in children.
Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
[TBL] [Abstract][Full Text] [Related]
12. Treatment of central diabetes insipidus in adults and children with desmopressin.
Ziai F; Walter R; Rosenthal IM
Arch Intern Med; 1978 Sep; 138(9):1382-5. PubMed ID: 686929
[TBL] [Abstract][Full Text] [Related]
13. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
14. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
Becker DJ; Foley TP
J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
Lee WP; Lippe BM; La Franchi SH; Kaplan SA
Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
17. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
Kim F; Towers HM
J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
Kosman ME
JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
[TBL] [Abstract][Full Text] [Related]
19. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
Hammer M; Vilhardt H
J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
[TBL] [Abstract][Full Text] [Related]
20. Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.
Atila C; Loughrey PB; Garrahy A; Winzeler B; Refardt J; Gildroy P; Hamza M; Pal A; Verbalis JG; Thompson CJ; Hemkens LG; Hunter SJ; Sherlock M; Levy MJ; Karavitaki N; Newell-Price J; Wass JAH; Christ-Crain M
Lancet Diabetes Endocrinol; 2022 Oct; 10(10):700-709. PubMed ID: 36007536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
